| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |